Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;71(3):467-70.
doi: 10.1111/j.1365-2125.2010.03839.x.

Improving the quality of drug research or simply increasing its cost? An evidence-based study of the cost for data monitoring in clinical trials

Esther Pronker  1 , Bart F Geerts, Adam Cohen, Herman Pieterse
Affiliations

Improving the quality of drug research or simply increasing its cost? An evidence-based study of the cost for data monitoring in clinical trials

Esther Pronker et al. Br J Clin Pharmacol. 2011 Mar.

Abstract

Aim: Procedures for verification of data from clinical studies are intended to maintain reliability for clinical trial results. Guidelines or legislations relating to clinical data management are of limited value and no study has yet demonstrated its effectiveness.

Method: Sponsor queries and dual entry procedures from one CRO on three different phase I trials are analysed on content, impact and cost.

Result: In this study, sponsor queries and dual entry procedures proved time and cost inefficient in detecting data discrepancies.

Conclusion: We advocate a more evidence-based approach for enhancing data integrity throughout the process of clinical data management.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histogram showing magnitude of differences between first and second data entry
See this image and copyright information in PMC

References

    1. Shuchman M. Commercializing clinical trials – risks and benefits of the CRO boom. N Engl J Med. 2007;357:1365–8. - PubMed
    1. Hughes B. 2007 FDA drug approvals: a year of flux. Nat Rev Drug Discov. 2008;7:107–9. - PubMed
    1. Califf RM. Clinical trials bureaucracy: unintended consequences of well-intentioned policy. Clin Trials. 2006;3:496–502. - PubMed
    1. Rondel RK, Varley SA, Webb CF. Clinical Data Management. Chichester: John Wiley and Sons; 2000.
    1. ICH Topic E 6 (R1) Guideline for Good Clinical Practice: CPMP/ICH/135/95. European Medicines Agency July 2002. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guidelin... (last accessed 19 November 2010)

MeSH terms